Los Angeles Chargers head coach Jim Harbaugh truly lives by "faith, family, football," and he called it "inspiring" to see other NFL stars so open about doing the same.

Invivyd (NASDAQ:IVVD – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright ...

Invivyd (NASDAQ:IVVD – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at D. Boral Capital in a ...

Los Angeles Chargers head coach Jim Harbaugh shared his view on the controversial tush push, saying teams either have to "get ...

Yahoo Sports NFL analyst Nate Tice is joined by fantasy analyst Matt Harmon and NFL writer Charles McDonald at the NFL ...

Yahoo Sports NFL analyst Nate Tice chats with the Los Angeles head coach about how the Chargers star quarterback fits into ...

In Regeneron Pharmaceuticals Inc.’s phase I/II Chord study of 12 children with genetic hearing loss tied to the variants of the otoferlin gene, 10 out of 11 have showed notable improvements in their ...

In a report released today, Patrick Trucchio from H.C. Wainwright maintained a Buy rating on Invivyd (IVVD – Research Report), with a price ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts disc ...

Find insight on Smith & Nephew, Raffles Medical Group and more in the latest Market Talks covering the Health Care sector.

Pemgarda has a standing emergency use authorization as a prophylaxis for immunocompromised patients, but FDA’s stringent ...

FDA denies Invivyd's EUA expansion for Pemgarda in Covid treatment while BioCryst reports positive Orladeyo data. AN2 changes endpoint, OS Therapies seeks partners & Eyenovia restructures.